Correlation Between Apogee Therapeutics, and Sellas Life
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Sellas Life Sciences, you can compare the effects of market volatilities on Apogee Therapeutics, and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Sellas Life.
Diversification Opportunities for Apogee Therapeutics, and Sellas Life
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Apogee and Sellas is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Sellas Life go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Sellas Life
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Sellas Life. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 2.38 times less risky than Sellas Life. The stock trades about -0.1 of its potential returns per unit of risk. The Sellas Life Sciences is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 107.00 in Sellas Life Sciences on November 3, 2024 and sell it today you would earn a total of 55.00 from holding Sellas Life Sciences or generate 51.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. Sellas Life Sciences
Performance |
| Timeline |
| Apogee Therapeutics, |
| Sellas Life Sciences |
Apogee Therapeutics, and Sellas Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and Sellas Life
The main advantage of trading using opposite Apogee Therapeutics, and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.| Apogee Therapeutics, vs. Lithia Motors | Apogee Therapeutics, vs. Contextlogic | Apogee Therapeutics, vs. Albertsons Companies | Apogee Therapeutics, vs. Titan Machinery |
| Sellas Life vs. NLS Pharmaceutics AG | Sellas Life vs. Mereo BioPharma Group | Sellas Life vs. Day One Biopharmaceuticals | Sellas Life vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |